-
Condition:
-
Country of Origin: USA
- Weight: 1.4 lb
- Serum/ Urine Test, CLIA Waived, 30 tests/kit (Continental US Only - including Alaska & Hawaii)
-
Learn more:
-
MFR:
Quidel Corporation
Ships from MFI Medical
-
MPN: 178
- Phone: (858) 552-1100
Frequently asked questions
What specific marker does this test detect?
This test is a sensitive, qualitative immunoassay designed for the detection of human chorionic gonadotrophin (hCG) to aid in the early determination of pregnancy.
Key features of the detection mechanism include:
- Analyte Target: The assay specifically detects hCG, which is often called the “pregnancy hormone.”
- Antibody Specificity: It utilizes a monoclonal antibody that is highly specific to the beta subunit of hCG.
- Sample Types: The test can be performed using either serum or urine samples.
- Technology: It operates using efficient, single-step immunoassay technology.
Is the QuickVue+ HCG test sensitive for early detection?
Yes, the Quidel Quickvue+ One-Step Hcg Combo Test is a highly sensitive immunoassay designed for the qualitative detection of human chorionic gonadotrophin (hCG), which supports early pregnancy diagnosis.
Key features that make this test effective and easy to use include:
- Dual Sample Capability: The test can be performed using both serum or urine samples.
- Highly Specific: It uses a monoclonal antibody specific to the beta subunit of hCG.
- Single-Step Technology: The assay employs an efficient, straightforward single-step testing process.
- Clear Readout: Results feature a clearly distinguishable +/- endpoint for unambiguous interpretation.
- CLIA Waived: This certification simplifies its use in facilities meeting CLIA requirements for waived testing.
Is the Quidel Quickvue+ One-Step Hcg Combo Test CLIA waived?
Yes, the Quidel Quickvue+ One-Step Hcg Combo Test is CLIA waived, potentially simplifying its use in various clinical settings.
Does the test provide clear results?
Yes, this sensitive, qualitative immunoassay is engineered for unambiguous interpretation. The results are indicated by a clearly distinguishable +/- endpoint, which ensures an easy and accurate reading of the Human Chorionic Gonadotrophin (hCG) detection. This straightforward display contributes to the test’s efficiency as a single-step testing technology.
Can this high-sensitivity test use serum or urine?
Yes, this highly sensitive diagnostic immunoassay is designed to detect human chorionic gonadotrophin (hCG) qualitatively in both serum and urine samples.
This dual capability makes it versatile for early pregnancy diagnosis across various clinical settings. It utilizes efficient, single-step technology and detects the beta subunit of hCG, yielding clear +/- endpoints for easy interpretation.
What convenient test kit sizes are offered?
The Quidel QuickVue+ One-Step HCG Combo Test is offered in two professional kit sizes, allowing flexibility based on your testing volume requirements: * 30 tests/kit* 90 tests/kitBoth configurations feature the CLIA Waived status and utilize the sensitive single-step immunoassay for qualitative detection of hCG in both serum or urine samples.
Does the test use a highly specific monoclonal antibody?
Yes, the Quidel Quickvue+ One-Step Hcg Combo Test utilizes a highly specific monoclonal antibody.
This feature is essential for the test’s single-step immunoassay technology, ensuring accurate qualitative detection of pregnancy.
- Target: The monoclonal antibody is specifically engineered to target the beta subunit of human chorionic gonadotrophin (hCG).
- Benefit: This high specificity is crucial for reliable results when performing early pregnancy diagnosis using either serum or urine samples.
Who is the manufacturer of the Quidel Quickvue+ One-Step Hcg Combo Test?
The Quidel Quickvue+ One-Step Hcg Combo Test is manufactured by Quidel Corporation.
Is the Quickvue+ HCG Combo Test highly sensitive?
Yes, the Quidel Quickvue+ One-Step Hcg Combo Test is designed for sensitive, qualitative detection of human chorionic gonadotrophin (hCG), making it an excellent tool for early pregnancy diagnosis.
Key benefits and features of this immunoassay include:
- High Specificity: It utilizes a monoclonal antibody specific to the beta subunit of hCG for accurate and targeted results.
- Dual Sample Compatibility: The test is applicable for use with both serum and urine samples.
- Efficient Technology: Features single-step immunoassay technology for fast and reliable detection.
- CLIA Waived Status: This product is CLIA Waived, simplifying its use and compliance in various clinical settings.
- Clear Interpretation: Results are provided via a clearly distinguishable +/- endpoint, minimizing ambiguity.
Does this test allow for early detection?
Yes, the Quidel Quickvue+ One-Step Hcg Combo Test is designed for the early detection of pregnancy, offering high sensitivity for accurate results.